相关实验视频

Updated: May 30, 2025

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

通过MCC950抑制NOD类受体蛋白3改善了患有败血症相关脑病变的老鼠的认知功能

Li Zhang¹, Long Ma², Yi Wang²

¹Xinjiang Medical University, Urumchi 830017, China; School of Nursing, Xinjiang Medical University, Urumchi 830054, China; Nursing Department The First Affiliated Hospital of Xinjiang Medical University, Urumchi 830054, China.

Journal of neuroimmunology

|January 29, 2025

概括

MCC950治疗显著改善了毒相关脑病变 (SAE) 的大鼠模型中的生存率和神经功能. 这表明MCC950是SAE的有前途的治疗剂.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
败血症研究败血症研究

背景情况:

败血症相关脑病变 (SAE) 是败血症的一种严重并发症.
目前对SAE的治疗方法有限,这凸显了对新型治疗策略的需求.

研究的目的:

在大鼠模型中研究MCC950对败血症相关脑病变 (SAE) 的治疗效果.
评估MCC950对SAE大鼠的生存,神经行为功能和生理参数的影响.

主要方法:

通过使用结和穿孔 (CLP) 方法建立了SAE的老鼠模型.
鼠接受了MCC950 (10 mg/kg) 或盐水的腹腔内注射.
评估了生存率,体重减轻,心率和神经行为变化 (使用复合神经反射功能的得分,光/黑暗盒子测试和开放场测试).

主要成果:

与对照组相比,MCC950治疗显著提高了SAE大鼠的生存率,并减少了体重减轻.
用MCC950治疗的SAE大鼠表现出神经功能得分的改善以及神经行为测试中的表现提高.
在SAE大鼠中,MCC950的使用导致心率降低.

结论:

MCC950在改善败血症相关脑病变的结果方面显示出显著的治疗潜力.
在SAE的临床前模型中,MCC950治疗对认知功能和生理参数产生了积极的影响.

关键词:

认知功能认知功能在MCC95050中,我们可以使用MCC950 这是一种NOD类受体蛋白3抑制剂.败血症相关的脑病变

更多相关视频

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.